BCG-induced cytokine release in bladder cancer cells is regulated by Ca 2+ signaling

Bacillus Calmette-Guérin (BCG) is widely used in the clinic to effectively treat superficial urinary bladder cancer. However, a significant proportion of patients who fail to respond to BCG risk cystectomy or death. Though more than 3 million cancer treatments with BCG occur annually, surprisingly l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular oncology 2019-02, Vol.13 (2), p.202-211
Hauptverfasser: Ibarra, Cristián, Karlsson, Marie, Codeluppi, Simone, Varas-Godoy, Manuel, Zhang, Songbai, Louhivuori, Lauri, Mangsbo, Sara, Hosseini, Arad, Soltani, Navid, Kaba, Rahim, Kalle Lundgren, T, Hosseini, Abolfazl, Tanaka, Nobuyuki, Oya, Mototsugu, Wiklund, Peter, Miyakawa, Ayako, Uhlén, Per
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 211
container_issue 2
container_start_page 202
container_title Molecular oncology
container_volume 13
creator Ibarra, Cristián
Karlsson, Marie
Codeluppi, Simone
Varas-Godoy, Manuel
Zhang, Songbai
Louhivuori, Lauri
Mangsbo, Sara
Hosseini, Arad
Soltani, Navid
Kaba, Rahim
Kalle Lundgren, T
Hosseini, Abolfazl
Tanaka, Nobuyuki
Oya, Mototsugu
Wiklund, Peter
Miyakawa, Ayako
Uhlén, Per
description Bacillus Calmette-Guérin (BCG) is widely used in the clinic to effectively treat superficial urinary bladder cancer. However, a significant proportion of patients who fail to respond to BCG risk cystectomy or death. Though more than 3 million cancer treatments with BCG occur annually, surprisingly little is known about the initial signaling cascades activated by BCG. Here, we report that BCG induces a rapid intracellular Ca (calcium ion) signal in bladder cancer cells that is essential for activating the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and for synthesizing and secreting proinflammatory cytokines, including interleukin 8 (IL-8). A similar Ca response was observed when cells were exposed to the supernatant of BCG. Studying cellular molecular mechanisms involved in the BCG signaling event, we found pivotal roles for phospholipase C and the Toll-like receptor 4. Further assessment revealed that this signaling pathway induces synthesis of IL-8, whereas exocytosis appeared to be controlled by global Ca signaling. These results shed new light on the molecular mechanisms underlying BCG treatment of bladder cancer, which can help in improving therapeutic efficacy and reducing adverse side effects.
doi_str_mv 10.1002/1878-0261.12397
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_484608</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2290257658</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1758-d619681df04b28b1fc33c992568bc384fa467698323f429503153d36a399bd993</originalsourceid><addsrcrecordid>eNo9kEtLAzEURoMotlbX7iTgUqbNY5JJljpoFQpu6jrkNSXtdKYmHaT_3hlbu7qXy_k-LgeAe4ymGCEyw6IQGSIcTzGhsrgA4_Plst9ZkWeFkHgEblJaI8S45PIajCiiTCCBx2D5Us6z0LjOegftYd9uQuNh9LXXycPQQFNr53yEVjd2GL6uEwypR1Zdrfd9yhxgqSF5gimsGl2HZnULripdJ393mhPw9fa6LN-zxef8o3xeZBYXTGSOY8kFdhXKDREGV5ZSKyVhXBhLRV7pnBdcCkpolRPJEMWMOso1ldI4KekEZMfe9ON3nVG7GLY6HlSrgzqdNv3mVS5yjkTPPx75XWy_O5_2at12sf85KUIkIqzgbKBmR8rGNqXoq3MvRmqwrgbHanCs_qz3iYdTb2e23p35f830Fy2QefE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2290257658</pqid></control><display><type>article</type><title>BCG-induced cytokine release in bladder cancer cells is regulated by Ca 2+ signaling</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>SWEPUB Freely available online</source><source>Wiley Online Library Open Access</source><source>PubMed Central</source><creator>Ibarra, Cristián ; Karlsson, Marie ; Codeluppi, Simone ; Varas-Godoy, Manuel ; Zhang, Songbai ; Louhivuori, Lauri ; Mangsbo, Sara ; Hosseini, Arad ; Soltani, Navid ; Kaba, Rahim ; Kalle Lundgren, T ; Hosseini, Abolfazl ; Tanaka, Nobuyuki ; Oya, Mototsugu ; Wiklund, Peter ; Miyakawa, Ayako ; Uhlén, Per</creator><creatorcontrib>Ibarra, Cristián ; Karlsson, Marie ; Codeluppi, Simone ; Varas-Godoy, Manuel ; Zhang, Songbai ; Louhivuori, Lauri ; Mangsbo, Sara ; Hosseini, Arad ; Soltani, Navid ; Kaba, Rahim ; Kalle Lundgren, T ; Hosseini, Abolfazl ; Tanaka, Nobuyuki ; Oya, Mototsugu ; Wiklund, Peter ; Miyakawa, Ayako ; Uhlén, Per</creatorcontrib><description>Bacillus Calmette-Guérin (BCG) is widely used in the clinic to effectively treat superficial urinary bladder cancer. However, a significant proportion of patients who fail to respond to BCG risk cystectomy or death. Though more than 3 million cancer treatments with BCG occur annually, surprisingly little is known about the initial signaling cascades activated by BCG. Here, we report that BCG induces a rapid intracellular Ca (calcium ion) signal in bladder cancer cells that is essential for activating the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and for synthesizing and secreting proinflammatory cytokines, including interleukin 8 (IL-8). A similar Ca response was observed when cells were exposed to the supernatant of BCG. Studying cellular molecular mechanisms involved in the BCG signaling event, we found pivotal roles for phospholipase C and the Toll-like receptor 4. Further assessment revealed that this signaling pathway induces synthesis of IL-8, whereas exocytosis appeared to be controlled by global Ca signaling. These results shed new light on the molecular mechanisms underlying BCG treatment of bladder cancer, which can help in improving therapeutic efficacy and reducing adverse side effects.</description><identifier>ISSN: 1574-7891</identifier><identifier>EISSN: 1878-0261</identifier><identifier>DOI: 10.1002/1878-0261.12397</identifier><identifier>PMID: 30358081</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Bacillus Calmette-Guerin vaccine ; BCG ; Bladder cancer ; Calcium (intracellular) ; Calcium - metabolism ; Calcium Signaling ; Calcium signalling ; Cancer ; Cell culture ; Cell Line, Tumor ; Cytokines ; Cytokines - metabolism ; Cytosol - metabolism ; Design ; Endoplasmic reticulum ; Exocytosis ; Experiments ; Humans ; Inflammation ; Interleukin 8 ; Interleukin-8 - metabolism ; Kinases ; Lymphocytes B ; Molecular modelling ; Mycobacterium bovis - metabolism ; NF-kappa B - metabolism ; Phospholipase C ; Proteins ; Signal transduction ; Toll-Like Receptor 4 - metabolism ; Toll-like receptors ; Tumors ; Urinary bladder ; Urinary Bladder Neoplasms - metabolism</subject><ispartof>Molecular oncology, 2019-02, Vol.13 (2), p.202-211</ispartof><rights>2018 The Authors. Published by FEBS Press and John Wiley &amp; Sons Ltd.</rights><rights>2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1758-d619681df04b28b1fc33c992568bc384fa467698323f429503153d36a399bd993</citedby><cites>FETCH-LOGICAL-c1758-d619681df04b28b1fc33c992568bc384fa467698323f429503153d36a399bd993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,550,776,780,860,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30358081$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:140199805$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Ibarra, Cristián</creatorcontrib><creatorcontrib>Karlsson, Marie</creatorcontrib><creatorcontrib>Codeluppi, Simone</creatorcontrib><creatorcontrib>Varas-Godoy, Manuel</creatorcontrib><creatorcontrib>Zhang, Songbai</creatorcontrib><creatorcontrib>Louhivuori, Lauri</creatorcontrib><creatorcontrib>Mangsbo, Sara</creatorcontrib><creatorcontrib>Hosseini, Arad</creatorcontrib><creatorcontrib>Soltani, Navid</creatorcontrib><creatorcontrib>Kaba, Rahim</creatorcontrib><creatorcontrib>Kalle Lundgren, T</creatorcontrib><creatorcontrib>Hosseini, Abolfazl</creatorcontrib><creatorcontrib>Tanaka, Nobuyuki</creatorcontrib><creatorcontrib>Oya, Mototsugu</creatorcontrib><creatorcontrib>Wiklund, Peter</creatorcontrib><creatorcontrib>Miyakawa, Ayako</creatorcontrib><creatorcontrib>Uhlén, Per</creatorcontrib><title>BCG-induced cytokine release in bladder cancer cells is regulated by Ca 2+ signaling</title><title>Molecular oncology</title><addtitle>Mol Oncol</addtitle><description>Bacillus Calmette-Guérin (BCG) is widely used in the clinic to effectively treat superficial urinary bladder cancer. However, a significant proportion of patients who fail to respond to BCG risk cystectomy or death. Though more than 3 million cancer treatments with BCG occur annually, surprisingly little is known about the initial signaling cascades activated by BCG. Here, we report that BCG induces a rapid intracellular Ca (calcium ion) signal in bladder cancer cells that is essential for activating the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and for synthesizing and secreting proinflammatory cytokines, including interleukin 8 (IL-8). A similar Ca response was observed when cells were exposed to the supernatant of BCG. Studying cellular molecular mechanisms involved in the BCG signaling event, we found pivotal roles for phospholipase C and the Toll-like receptor 4. Further assessment revealed that this signaling pathway induces synthesis of IL-8, whereas exocytosis appeared to be controlled by global Ca signaling. These results shed new light on the molecular mechanisms underlying BCG treatment of bladder cancer, which can help in improving therapeutic efficacy and reducing adverse side effects.</description><subject>Bacillus Calmette-Guerin vaccine</subject><subject>BCG</subject><subject>Bladder cancer</subject><subject>Calcium (intracellular)</subject><subject>Calcium - metabolism</subject><subject>Calcium Signaling</subject><subject>Calcium signalling</subject><subject>Cancer</subject><subject>Cell culture</subject><subject>Cell Line, Tumor</subject><subject>Cytokines</subject><subject>Cytokines - metabolism</subject><subject>Cytosol - metabolism</subject><subject>Design</subject><subject>Endoplasmic reticulum</subject><subject>Exocytosis</subject><subject>Experiments</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Interleukin 8</subject><subject>Interleukin-8 - metabolism</subject><subject>Kinases</subject><subject>Lymphocytes B</subject><subject>Molecular modelling</subject><subject>Mycobacterium bovis - metabolism</subject><subject>NF-kappa B - metabolism</subject><subject>Phospholipase C</subject><subject>Proteins</subject><subject>Signal transduction</subject><subject>Toll-Like Receptor 4 - metabolism</subject><subject>Toll-like receptors</subject><subject>Tumors</subject><subject>Urinary bladder</subject><subject>Urinary Bladder Neoplasms - metabolism</subject><issn>1574-7891</issn><issn>1878-0261</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>D8T</sourceid><recordid>eNo9kEtLAzEURoMotlbX7iTgUqbNY5JJljpoFQpu6jrkNSXtdKYmHaT_3hlbu7qXy_k-LgeAe4ymGCEyw6IQGSIcTzGhsrgA4_Plst9ZkWeFkHgEblJaI8S45PIajCiiTCCBx2D5Us6z0LjOegftYd9uQuNh9LXXycPQQFNr53yEVjd2GL6uEwypR1Zdrfd9yhxgqSF5gimsGl2HZnULripdJ393mhPw9fa6LN-zxef8o3xeZBYXTGSOY8kFdhXKDREGV5ZSKyVhXBhLRV7pnBdcCkpolRPJEMWMOso1ldI4KekEZMfe9ON3nVG7GLY6HlSrgzqdNv3mVS5yjkTPPx75XWy_O5_2at12sf85KUIkIqzgbKBmR8rGNqXoq3MvRmqwrgbHanCs_qz3iYdTb2e23p35f830Fy2QefE</recordid><startdate>201902</startdate><enddate>201902</enddate><creator>Ibarra, Cristián</creator><creator>Karlsson, Marie</creator><creator>Codeluppi, Simone</creator><creator>Varas-Godoy, Manuel</creator><creator>Zhang, Songbai</creator><creator>Louhivuori, Lauri</creator><creator>Mangsbo, Sara</creator><creator>Hosseini, Arad</creator><creator>Soltani, Navid</creator><creator>Kaba, Rahim</creator><creator>Kalle Lundgren, T</creator><creator>Hosseini, Abolfazl</creator><creator>Tanaka, Nobuyuki</creator><creator>Oya, Mototsugu</creator><creator>Wiklund, Peter</creator><creator>Miyakawa, Ayako</creator><creator>Uhlén, Per</creator><general>John Wiley &amp; Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope></search><sort><creationdate>201902</creationdate><title>BCG-induced cytokine release in bladder cancer cells is regulated by Ca 2+ signaling</title><author>Ibarra, Cristián ; Karlsson, Marie ; Codeluppi, Simone ; Varas-Godoy, Manuel ; Zhang, Songbai ; Louhivuori, Lauri ; Mangsbo, Sara ; Hosseini, Arad ; Soltani, Navid ; Kaba, Rahim ; Kalle Lundgren, T ; Hosseini, Abolfazl ; Tanaka, Nobuyuki ; Oya, Mototsugu ; Wiklund, Peter ; Miyakawa, Ayako ; Uhlén, Per</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1758-d619681df04b28b1fc33c992568bc384fa467698323f429503153d36a399bd993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Bacillus Calmette-Guerin vaccine</topic><topic>BCG</topic><topic>Bladder cancer</topic><topic>Calcium (intracellular)</topic><topic>Calcium - metabolism</topic><topic>Calcium Signaling</topic><topic>Calcium signalling</topic><topic>Cancer</topic><topic>Cell culture</topic><topic>Cell Line, Tumor</topic><topic>Cytokines</topic><topic>Cytokines - metabolism</topic><topic>Cytosol - metabolism</topic><topic>Design</topic><topic>Endoplasmic reticulum</topic><topic>Exocytosis</topic><topic>Experiments</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Interleukin 8</topic><topic>Interleukin-8 - metabolism</topic><topic>Kinases</topic><topic>Lymphocytes B</topic><topic>Molecular modelling</topic><topic>Mycobacterium bovis - metabolism</topic><topic>NF-kappa B - metabolism</topic><topic>Phospholipase C</topic><topic>Proteins</topic><topic>Signal transduction</topic><topic>Toll-Like Receptor 4 - metabolism</topic><topic>Toll-like receptors</topic><topic>Tumors</topic><topic>Urinary bladder</topic><topic>Urinary Bladder Neoplasms - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ibarra, Cristián</creatorcontrib><creatorcontrib>Karlsson, Marie</creatorcontrib><creatorcontrib>Codeluppi, Simone</creatorcontrib><creatorcontrib>Varas-Godoy, Manuel</creatorcontrib><creatorcontrib>Zhang, Songbai</creatorcontrib><creatorcontrib>Louhivuori, Lauri</creatorcontrib><creatorcontrib>Mangsbo, Sara</creatorcontrib><creatorcontrib>Hosseini, Arad</creatorcontrib><creatorcontrib>Soltani, Navid</creatorcontrib><creatorcontrib>Kaba, Rahim</creatorcontrib><creatorcontrib>Kalle Lundgren, T</creatorcontrib><creatorcontrib>Hosseini, Abolfazl</creatorcontrib><creatorcontrib>Tanaka, Nobuyuki</creatorcontrib><creatorcontrib>Oya, Mototsugu</creatorcontrib><creatorcontrib>Wiklund, Peter</creatorcontrib><creatorcontrib>Miyakawa, Ayako</creatorcontrib><creatorcontrib>Uhlén, Per</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>Molecular oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ibarra, Cristián</au><au>Karlsson, Marie</au><au>Codeluppi, Simone</au><au>Varas-Godoy, Manuel</au><au>Zhang, Songbai</au><au>Louhivuori, Lauri</au><au>Mangsbo, Sara</au><au>Hosseini, Arad</au><au>Soltani, Navid</au><au>Kaba, Rahim</au><au>Kalle Lundgren, T</au><au>Hosseini, Abolfazl</au><au>Tanaka, Nobuyuki</au><au>Oya, Mototsugu</au><au>Wiklund, Peter</au><au>Miyakawa, Ayako</au><au>Uhlén, Per</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>BCG-induced cytokine release in bladder cancer cells is regulated by Ca 2+ signaling</atitle><jtitle>Molecular oncology</jtitle><addtitle>Mol Oncol</addtitle><date>2019-02</date><risdate>2019</risdate><volume>13</volume><issue>2</issue><spage>202</spage><epage>211</epage><pages>202-211</pages><issn>1574-7891</issn><eissn>1878-0261</eissn><abstract>Bacillus Calmette-Guérin (BCG) is widely used in the clinic to effectively treat superficial urinary bladder cancer. However, a significant proportion of patients who fail to respond to BCG risk cystectomy or death. Though more than 3 million cancer treatments with BCG occur annually, surprisingly little is known about the initial signaling cascades activated by BCG. Here, we report that BCG induces a rapid intracellular Ca (calcium ion) signal in bladder cancer cells that is essential for activating the transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and for synthesizing and secreting proinflammatory cytokines, including interleukin 8 (IL-8). A similar Ca response was observed when cells were exposed to the supernatant of BCG. Studying cellular molecular mechanisms involved in the BCG signaling event, we found pivotal roles for phospholipase C and the Toll-like receptor 4. Further assessment revealed that this signaling pathway induces synthesis of IL-8, whereas exocytosis appeared to be controlled by global Ca signaling. These results shed new light on the molecular mechanisms underlying BCG treatment of bladder cancer, which can help in improving therapeutic efficacy and reducing adverse side effects.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>30358081</pmid><doi>10.1002/1878-0261.12397</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1574-7891
ispartof Molecular oncology, 2019-02, Vol.13 (2), p.202-211
issn 1574-7891
1878-0261
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_484608
source MEDLINE; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; SWEPUB Freely available online; Wiley Online Library Open Access; PubMed Central
subjects Bacillus Calmette-Guerin vaccine
BCG
Bladder cancer
Calcium (intracellular)
Calcium - metabolism
Calcium Signaling
Calcium signalling
Cancer
Cell culture
Cell Line, Tumor
Cytokines
Cytokines - metabolism
Cytosol - metabolism
Design
Endoplasmic reticulum
Exocytosis
Experiments
Humans
Inflammation
Interleukin 8
Interleukin-8 - metabolism
Kinases
Lymphocytes B
Molecular modelling
Mycobacterium bovis - metabolism
NF-kappa B - metabolism
Phospholipase C
Proteins
Signal transduction
Toll-Like Receptor 4 - metabolism
Toll-like receptors
Tumors
Urinary bladder
Urinary Bladder Neoplasms - metabolism
title BCG-induced cytokine release in bladder cancer cells is regulated by Ca 2+ signaling
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T20%3A22%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=BCG-induced%20cytokine%20release%20in%20bladder%20cancer%20cells%20is%20regulated%20by%20Ca%202+%20signaling&rft.jtitle=Molecular%20oncology&rft.au=Ibarra,%20Cristi%C3%A1n&rft.date=2019-02&rft.volume=13&rft.issue=2&rft.spage=202&rft.epage=211&rft.pages=202-211&rft.issn=1574-7891&rft.eissn=1878-0261&rft_id=info:doi/10.1002/1878-0261.12397&rft_dat=%3Cproquest_swepu%3E2290257658%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2290257658&rft_id=info:pmid/30358081&rfr_iscdi=true